Evolent Health, Inc. (EVH)
4.90
+0.13
(+2.73%)
USD |
NYSE |
Nov 13, 16:00
4.90
0.00 (0.00%)
After-Hours: 19:59
Evolent Health Enterprise Value : 1.372B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.372B |
| November 12, 2026 | 1.358B |
| November 11, 2026 | 1.383B |
| November 10, 2026 | 1.361B |
| November 09, 2026 | 1.351B |
| November 06, 2026 | 1.336B |
| November 05, 2026 | 1.332B |
| November 04, 2026 | 1.361B |
| November 03, 2026 | 1.305B |
| November 02, 2026 | 1.322B |
| October 30, 2026 | 1.305B |
| October 29, 2026 | 1.299B |
| October 28, 2026 | 1.308B |
| October 27, 2026 | 1.318B |
| October 26, 2026 | 1.331B |
| October 23, 2026 | 1.361B |
| October 22, 2026 | 1.371B |
| October 21, 2026 | 1.365B |
| October 20, 2026 | 1.369B |
| October 19, 2026 | 1.325B |
| October 16, 2026 | 1.335B |
| October 15, 2026 | 1.369B |
| October 14, 2026 | 1.353B |
| October 13, 2026 | 1.339B |
| October 12, 2026 | 1.299B |
| Date | Value |
|---|---|
| October 09, 2026 | 1.275B |
| October 08, 2026 | 1.266B |
| October 07, 2026 | 1.287B |
| October 06, 2026 | 1.253B |
| October 05, 2026 | 1.227B |
| October 02, 2026 | 1.210B |
| October 01, 2026 | 1.202B |
| September 30, 2026 | 1.213B |
| September 29, 2026 | 1.228B |
| September 28, 2026 | 1.243B |
| September 25, 2026 | 1.239B |
| September 24, 2026 | 1.228B |
| September 23, 2026 | 1.240B |
| September 22, 2026 | 1.260B |
| September 21, 2026 | 1.248B |
| September 18, 2026 | 1.248B |
| September 17, 2026 | 1.245B |
| September 16, 2026 | 1.253B |
| September 15, 2026 | 1.253B |
| September 14, 2026 | 1.294B |
| September 11, 2026 | 1.304B |
| September 10, 2026 | 1.302B |
| September 09, 2026 | 1.299B |
| September 08, 2026 | 1.307B |
| September 04, 2026 | 1.319B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DarioHealth Corp. | 15.13M |
| CompuMed, Inc. | 5.971M |
| Teladoc Health, Inc. | 1.789B |
| Renalytix Plc | 30.92M |
| DaVita, Inc. | 25.53B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.57M |
| Revenue (Quarterly) | 725.37M |
| Total Expenses (Quarterly) | 748.93M |
| EPS Diluted (Quarterly) | -0.2084 |
| Gross Profit Margin (Quarterly) | 9.19% |
| Profit Margin (Quarterly) | -3.25% |
| Earnings Yield | -92.72% |
| Normalized Earnings Yield | -38.51 |